OPINION

RAS: a moving target

Ras oncogene means different things to different tumours in different tissues. Step away from RAS itself and we enter a universe of complex and diverse biological processes that Ras oncogene orchestrates. In my view, deep…

Read More


What is fair pricing in oncology?

Finding a balance between price and availability of innovative therapies is complicated. Each stakeholder, from the patient and healthcare systems to research and development (R&D) companies, has a very different view of fair pricing for…

Read More

Finding the right balance to manage frail patients

Managing frail patients reminds us of one of the biggest challenges in oncology – the need to treat the right patients, not all patients. Frailty is generally accepted as a state of vulnerability to adverse…

Read More